Extreme Phenotype of Epidermal Growth Factor Receptor Inhibitor-induced Destructive Folliculitis.

about

Extreme Phenotype of Epidermal Growth Factor Receptor Inhibitor-induced Destructive Folliculitis.

Item

http://www.wikidata.org/entity/Q41950779

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Extreme Phenotype of Epidermal ...... uced Destructive Folliculitis.

@en

type

Item

label

Extreme Phenotype of Epidermal ...... uced Destructive Folliculitis.

@en

prefLabel

Extreme Phenotype of Epidermal ...... uced Destructive Folliculitis.

@en

P1476

Extreme Phenotype of Epidermal ...... uced Destructive Folliculitis.

@en

P2093

Alexander A Navarini

http://www.w3.org/2001/XMLSchema#string

Barbara Meier

http://www.w3.org/2001/XMLSchema#string

Florian Anzengruber

http://www.w3.org/2001/XMLSchema#string

Julia-Tatjana Maul

http://www.w3.org/2001/XMLSchema#string

Katrin Kerl

http://www.w3.org/2001/XMLSchema#string

P2860

Cutaneous side-effects of EGFR inhibitors and their management.

Skin problems and EGFR-tyrosine kinase inhibitor

Review of epidermal growth factor receptor biology.

Current situation of Panitumumab, Matuzumab, Nimotuzumab and Zalutumumab.

The Inflammasome and the Epidermal Growth Factor Receptor (EGFR) Are Involved in the Staphylococcus aureus-Mediated Induction of IL-1alpha and IL-1beta in Human Keratinocytes.

Dermatologic side effects associated with the epidermal growth factor receptor inhibitors.

An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway.

Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors.

Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management.

Erosive pustular dermatosis of the scalp-like eruption due to gefitinib: case report and review of the literature of alopecia associated with EGFR inhibitors.

P304

176-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4103/0974-7753.203174

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lars E French

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28442875

http://www.w3.org/2001/XMLSchema#string

P932

5387879

http://www.w3.org/2001/XMLSchema#string